Belgium vs Korea: Proportion of isolates with decreased susceptibility or resistance
Belgium
0.6
in 2020
Korea
0
in 2018
Belgium rank
10th
Korea rank
13th
Proportion of isolates with decreased susceptibility or resistance over time
- Belgium
- Korea
How they compare
Belgium currently reports 0.6 against 0 in Korea, a difference of 0.6.
Across all 8 years both countries report, Korea has been ahead every year.
Belgium ranks 10th and Korea ranks 13th of 52 countries.
Korea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Belgium | Korea | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 | 29.27 | 29.27 | Korea |
| 2010s | 0 | 16.65 | 16.65 | Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Belgium or Korea?
- Belgium, at 0.6 against 0 in Korea as of 2020.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Belgium and Korea?
- 0.6, with Belgium ahead.
- How many years of comparable data are there for Belgium and Korea?
- 8 years are reported by both, from 2009 to 2018.
- How do Belgium and Korea rank globally for proportion of isolates with decreased susceptibility or resistance?
- Belgium ranks 10th and Korea ranks 13th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.